ProJuvant™ (Pluronic F127®/chitosan) enhances the immune response to intranasally administered tetanus toxoid

This publication has 46 references indexed in Scilit:

• Carbohydrate Biopolymers Enhance Antibody Responses to Mucosally Delivered Vaccine Antigens
  Infection and Immunity, 2000
• Monophosphoryl lipid A enhances mucosal and systemic immunity to vaccine antigens following intranasal administration
  Vaccine, 2000
• Mucosally Induced Immunoglobulin E-Associated Inflammation in the Respiratory Tract
  Infection and Immunity, 2000
• Effect of chitosan on epithelial permeability and structure
  International Journal of Pharmaceutics, 1999
• Immunostimulatory DNA Is a Potent Mucosal Adjuvant
  Cellular Immunology, 1998
• Systemic and mucosal immune responses of mice to aluminium-adsorbed or aluminium-non-adsorbed tetanus toxoid administered intranasally with recombinant cholera toxin B subunit
  Vaccine, 1998
• Acute and chronic response to vanadium following two methods of streptozotocin-diabetes induction
  Canadian Journal of Physiology and Pharmacology, 1997
• Intranasal immunization of mice against influenza with synthetic peptides anchored to proteosomes
  Vaccine, 1995
• Effects of cholera toxin adjuvant on IgE antibody response to orally or nasally administered ovalbumin
  Vaccine, 1994
• Escherichia coli heat-labile enterotoxin B subunits supplemented with a trace amount of the holotoxin as an adjuvant for nasal influenza vaccine
  Vaccine, 1994